Loperamide
Loperamide is an intervention with 41 clinical trials. Currently 5 active trials ongoing. Historical success rate of 80.6%.
Success Metrics
Based on 25 completed trials
Phase Distribution
Phase Distribution
12
Early Stage
16
Mid Stage
9
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
80.6%
25 of 31 finished
19.4%
6 ended early
5
trials recruiting
41
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
E7 TCR T Cells for Human Papillomavirus-Associated Cancers
Rash & Diarrhea Prophylaxis With Capivasertib
Sunitinib or Cediranib for Alveolar Soft Part Sarcoma
A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has Spread
Clinical Trials (41)
Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
E7 TCR T Cells for Human Papillomavirus-Associated Cancers
Rash & Diarrhea Prophylaxis With Capivasertib
Sunitinib or Cediranib for Alveolar Soft Part Sarcoma
A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has Spread
Sacituzumab Govitecan for Relapsed Ovarian, Endometrial, and Cervical Carcinomas
Preventive stRategy for IMMU132-relatED AEs in TNBC or Luminal Breast Cancer- PRIMED
Probiotics for Prevention of Neratinib-Induced Diarrhea in Breast Cancer Patients
Incidence and Severity of Diarrhea in Patients With HER2 Positive Breast Cancer Treated With Trastuzumab and Neratinib
Single Dose Antibiotic Treatment of Acute Watery Diarrhea, Rifaximin Versus Azithromycin, With Loperamide Adjunct
Three Antidiarrheal Strategies in HER2+/HR+ Early Breast Cancer Patients Treated With Extended Adjuvant Neratinib
A Study to Evaluate the Effects of Loperamide (JNJ-289679) on Electrocardiogram Intervals in Healthy Adult Participants
Indenoisoquinoline LMP744 in Adults With Relapsed Solid Tumors and Lymphomas
Topical Loperamide Gel for Pain Reduction During Repeat Finger Lancing
A Study of Poziotinib in Patients With Epidermal Growth Factor Receptor (EGFR) or Human Epidermal Growth Factor Receptor 2 (HER2) Activating Mutations in Advanced Malignancies
A Study to Characterize Colon Pathology in Patients With HER2 Amplified Breast Cancer Treated With Neratinib
Effect of Montmorillonite Power or Loperamide on the Pharmacokinetics of Pyrotinib in Healthy Subjects
A Drug-drug Interaction Trial of Loperamide Pharmacokinetics Effect on Pyrotinib Maleate
Gut Transit Effect on Enterohepatic Circulation
An Open-Label Study to Characterize the Incidence and Severity of Diarrhea in Patients With Early-Stage HER2+ Breast Cancer Treated With Neratinib and Loperamide
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 41